retatrutide what is retatrutide clinical trials trial information Safety, Side Effects & Provider Use Dosing: Early Clinical Trial – Retatrutide Phase 3: TRIUMPH Program

A small but significant increase in the heart rate (by 1 bpm) was noted, which, according to the literature, has no meaningful health implications

Arrow direction reflects correlation with the PC, and length indicates the strength of contribution (scaled for visibility)

Side effect management: Common adverse effects of tirzepatide include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and decreased appetite, which occur in 2040% of patients, particularly during dose escalation

doi: 10.1080/08989629908573933

A: Clinical improvement timelines may vary depending on the individuals health status and degree of deficiency